Innovative Blood Test Combining Two Methods Boosts Early Detection of Colorectal Cancer
A new blood test combining immunoprecipitation and multiplex digital PCR offers high accuracy in early colorectal cancer detection with minimal blood volume, promising to improve screening and patient outcomes.
Recent advancements in medical research have introduced a groundbreaking blood test that significantly improves early detection of colorectal cancer (CRC). The number of young individuals under 50 diagnosed with CRC is rising globally, especially in high-income nations, with factors such as Western diets, obesity, limited physical activity, and antibiotic use in early life being potential contributors.
Early diagnosis is crucial because the chances of successful treatment increase dramatically with prompt detection. To address this, researchers from Hahn-Schickard, in collaboration with the University Hospital Schleswig-Holstein and the German Cancer Research Center, have developed a novel blood testing method aimed at identifying cancer markers with higher precision while requiring minimal blood volume.
This new approach, detailed in the journal 31Analytical Chemistry31, involves an innovative combination of immunoprecipitation and multiplex digital PCR—two well-established techniques. The integration allows for high diagnostic accuracy, even with a small blood sample of just 500 microliters, roughly one-fifth of a teaspoon. In a pilot study involving 32 CRC patients and 29 control subjects, the test achieved an impressive sensitivity of 85% and specificity of 90%, outperforming existing methods that require larger blood volumes.
The method holds promise for becoming part of routine screening, especially as it minimizes the practical hurdles associated with traditional tests. Developing the test further, young scientist Judith Sum aims to incorporate additional markers to enhance diagnostic precision. Furthermore, the research team emphasizes raising awareness of the rising CRC risk among younger populations and encourages proactive health monitoring.
While more extensive studies are necessary before clinical implementation, this development marks a significant step forward in non-invasive cancer diagnostics, potentially enabling earlier interventions and better patient outcomes.
Source: https://medicalxpress.com/news/2025-07-coupling-methods-possibilities-early-colorectal.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
UK Confronts Anti-Vaccine Misinformation Following Child’s Death from Measles
Following a child's death from measles, UK health officials are battling misinformation and vaccine hesitancy that threaten to undermine vaccination efforts and public health.
Innovative Dual-Drug Approach Shows Potential in Treating Aggressive Leukemia
A new combination therapy using Menin inhibitors and a novel drug shows promise in treating aggressive forms of acute myeloid leukemia, potentially improving patient outcomes and overcoming drug resistance.
Emerging Therapies Reduce Need for Surgery in Ulcerative Colitis Patients
A 20-year study shows that new targeted therapies for ulcerative colitis have led to a significant decrease in the need for surgical removal of the colon, improving patient outcomes.
A Common Parasite Could Harm Human Sperm and Impact Male Fertility
Emerging evidence suggests that the parasite *Toxoplasma gondii* can invade human reproductive organs and damage sperm, potentially contributing to male infertility. Prevention through good hygiene and food safety is essential.